BioPorto Logo.png
Grant of Warrants
September 22, 2023 12:59 ET | BioPorto A/S
September 22, 2023Announcement no. 16 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, September 22, 2023, (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the...
BioPorto Logo.png
BioPorto Initiates Search for new CFO as Neil Goldman Resigns  
September 19, 2023 09:16 ET | BioPorto A/S
September 19, 2023Announcement no. 15 BioPorto Initiates Search for new CFO as Neil Goldman Resigns COPENHAGEN, DENMARK and BOSTON, MA, USA, September 19, 2023, (GLOBE NEWSWIRE) – BioPorto A/S...
BioPorto Logo.png
BioPorto Provides Update on NGAL Test Regulatory Pathway
September 11, 2023 02:30 ET | BioPorto A/S
September 11, 2023 News release BioPorto Provides Update on NGAL Test Regulatory Pathway COPENHAGEN, DENMARK and BOSTON, MA, September 11, 2023, (GLOBE NEWSWIRE) -- BioPorto A/S...
BioPorto Logo.png
BioPorto to Participate in Upcoming Investor Conferences
August 28, 2023 11:32 ET | BioPorto A/S
August 28, 2023 News release BioPorto to Participate in Upcoming Investor Conferences COPENHAGEN, DENMARK and BOSTON, MA, August 28, 2023, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or...
BioPorto Logo.png
BioPorto Announces Interim Results for the First Six Months of 2023
August 01, 2023 02:48 ET | BioPorto A/S
August 1, 2023Announcement no. 14 BioPorto Announces Interim Results for the First Six Months of 2023 COPENHAGEN, Denmark and BOSTON, MA, USA, August 1, 2023, (GLOBE NEWSWIRE) -- BioPorto A/S...
BioPorto Logo.png
BioPorto A/S to Host Second Quarter 2023 Earnings Webcast and Analyst Call
July 07, 2023 08:55 ET | BioPorto A/S
July 7, 2023News Release BioPorto A/S to Host Second Quarter 2023 Earnings Webcast and Analyst Call COPENHAGEN, Denmark and BOSTON, MA, USA, July 7, 2023, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto...
BioPorto Logo.png
BioPorto Announces Submission of Response to FDA Additional Information Letter
June 29, 2023 02:11 ET | BioPorto A/S
June 29, 2023News release BioPorto Announces Submission of Response to FDA Additional Information Letter COPENHAGEN, DENMARK and BOSTON, MA, June 29, 2023, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto...
BioPorto Logo.png
Managers’ transactions
June 28, 2023 09:50 ET | BioPorto A/S
June 28, 2023Announcement no. 13 Managers’ transactions In connection with the completion of BioPorto A/S’ rights issue as described in...
BioPorto Logo.png
BioPorto A/S announces completion of rights issue; total number of shares and voting rights
June 23, 2023 01:49 ET | BioPorto A/S
June 23, 2023Announcement no. 12 BioPorto A/S announces completion of rights issue; total number of shares and voting rights COPENHAGEN, Denmark and BOSTON, MA, USA, June 23, 2023, (GLOBE NEWSWIRE)...
BioPorto Logo.png
BioPorto A/S announces results of rights issue
June 21, 2023 07:52 ET | BioPorto A/S
June 21, 2023Announcement no. 11 BioPorto A/S announces results of rights issue COPENHAGEN, Denmark and BOSTON, MA, USA, June 21, 2023, (GLOBE NEWSWIRE) -- BioPorto A/S (“BioPorto” or the “Company”)...